×
STERIS Cash on Hand 2010-2025 | STE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
STERIS cash on hand for the quarter ending March 31, 2025 was
$0.172B
, a
17.06% decline
year-over-year.
STERIS cash on hand for 2025 was
$0.172B
, a
17.06% decline
from 2024.
STERIS cash on hand for 2024 was
$0.207B
, a
0.64% decline
from 2023.
STERIS cash on hand for 2023 was
$0.208B
, a
40.18% decline
from 2022.
View More
STERIS Cash on Hand 2010-2025 | STE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
STERIS cash on hand for 2025 was
$0.172B
, a
17.06% decline
from 2024.
STERIS cash on hand for 2024 was
$0.207B
, a
0.64% decline
from 2023.
STERIS cash on hand for 2023 was
$0.208B
, a
40.18% decline
from 2022.
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$185B
Thermo Fisher Scientific (TMO)
$152.9B
Edwards Lifesciences (EW)
$44.9B
Alcon (ALC)
$43B
IDEXX Laboratories (IDXX)
$41.9B
DexCom (DXCM)
$32.9B
IQVIA Holdings (IQV)
$27.5B
Mettler-Toledo (MTD)
$24.2B
SONOVA HOLDING (SONVY)
$17.2B
Waters (WAT)
$16.8B
Hologic (HOLX)
$14.2B
Sysmex ADR (SSMXY)
$10.5B
Penumbra (PEN)
$8.9B
Masimo (MASI)
$8.4B
Globus Medical (GMED)
$7B
Glaukos (GKOS)
$5.5B
Teleflex (TFX)
$4.9B
Integer Holdings (ITGR)
$3.9B
TransMedics (TMDX)
$3.5B
PROCEPT BioRobotics (PRCT)
$3.2B
LivaNova (LIVN)
$2.3B
Nihon Kohden (NHNKY)
$2.2B
Elekta AB (EKTAY)
$1.9B
Veracyte (VCYT)
$1.8B
Alphatec Holdings (ATEC)
$1.5B
Artivion (AORT)
$1.3B
OPKO Health (OPK)
$1.1B
Paragon 28 (FNA)
$1.1B
Pulse Biosciences (PLSE)
$1B
Tandem Diabetes Care (TNDM)
$974M